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Abstract
Background: Excess abdominal adiposity cause metabolic disturbances, particularly in pregnancy. Methods of
accurate measurement are limited in pregnancy due to risks associated with these procedures. This study outlines a
non-invasive methodology for the measurement of adipose tissue in pregnancy and determines the intra- and
inter-observer reliability of ultrasound (US) measurements of the two components of adipose tissue (subcutaneous
(SAT) and visceral adipose tissue (VAT)) within a pregnant population.
Methods: Thirty pregnant women were recruited at the end of their first trimester, from routine antenatal clinic at
the University Maternity Hospital Limerick, Ireland. Measurements of adipose tissue thickness were obtained using a
GE Voluson E8 employing a 1–5 MHz curvilinear array transducer. Two observers, employing methodological rigour
in US technique, measured thickness of adipose tissue three times, and segmented the US image systematically in
order to define measurements of SAT and VAT using specifically pre-defined anatomical landmarks.
Results: Intra-observer and inter-observer precision was assessed using Coefficient of Variation (CV). Measurements
of SAT and total adipose for both observers were < 5% CV and < 10% CV for VAT in measures by both observers.
Inter-observer reliability was assessed by Limits of Agreement (LoA). LoA were determined to be − 0.45 to 0.46 cm
for SAT and − 0.34 to 0.53 cm for VAT values. Systematic bias of SAT measurement was 0.01 cm and 0.10 cm for VAT.
Inter-observer precision was also assessed by coefficient of variation (CV: SAT, 3.1%; VAT, 7.2%; Total adipose, 3.0%).
Conclusion: Intra-observer precision was found to be acceptable for measures of SAT, VAT and total adipose
according to anthropometric criterion, with higher precision reported in SAT values than in VAT. Inter-observer
reliability assessed by Limits-Of-Agreement (LoA) confirm anthropometrically reliable to 0.5 cm. Systematic bias was
minimal for both measures, falling within 95% confidence intervals. These results suggest that US can produce
reliable, repeatable and accurate measures of SAT and VAT during pregnancy.
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Background
Ultrasound (US) has been used effectively to assess body
fat for decades [1]. Limitations to its use are due to lack
of standardization of technique, and data on repeatability
amongst different operators [2, 3]. The current gold
standard for the quantitative assessment of intra-
abdominal adipose tissue uses computed tomography
(CT) scanning [4]. Validity and reproducibility of ultra-
sound techniques against CT scanning has been previ-
ously assessed [5–8] in non-pregnant populations, and
reportedly the inter-observer correlation coefficient of
the mean ultrasound distance was 0.94 (P < 0.001), and
coefficient of variation 5.4% within a non-pregnant
population [7]. Other methods for quantifying risk using
abdominal measures and ratios of these, are; DXA scan-
ning, waist: hip circumference ratio, and anthropometric
skinfold measurements. However, during pregnancy
these three techniques have distinct disadvantages,
which render them inadequate within a clinical setting
and in a pregnant population [9, 10]. Limitations include
exposure to ionising radiation, expense, lack of valid-
ation of technique, time-consuming techniques and re-
quirement of a trained skilful measurer [9, 10].
Despite methods of capturing body composition being
limited within a pregnant population, the use of ultra-
sound to measure abdominal adipose tissue has been re-
cently reviewed and found to be a useful tool for
measuring body composition non-invasively [2, 3]. While
US requires skill and training with a cost implication,
pregnant women undergo US by a skilled ultra-
sonographer at the end of the first trimester, as part of
routine care, making this a contact point with healthcare
professionals with potential opportunity for measure-
ments to be carried out. Measuring components of ab-
dominal adipose tissue- visceral adipose tissue (VAT)
and subcutaneous adipose tissue (SAT), are of particular
current relevance and importance as these depots of
adiposity have been implicated in the pathogenesis of
metabolic and cardiovascular health in non-pregnant
populations [3, 11, 12], as well as in a pregnant popula-
tion [13].
Maternal obesity has been linked to increased morbid-
ity and mortality in pregnancy putting both the mother
and infant at risk in the short and long term [14, 15].
Large population studies looking at pregnancy outcomes
based on the World Health Organisation (WHO) body
mass index (BMI) sub-classifications of obesity [16]
found a relationship to increasing risk of adverse out-
comes, including gestational diabetes, hypertensive dis-
orders, caesarean section, macrosomia, admission to
neonatal unit and neonatal hypoglycaemia [15, 17, 18].
However, BMI does not provide insight into components
of body composition, such as lean tissue, subcutaneous
or visceral adipose tissue which are known to exert
different physiological effects in the pregnancy state [19].
Crude measures of adipose thickness such as that pos-
sible via ultrasound, provide a non-invasive technique
for insight into subcutaneous and visceral adipose com-
partments of body composition. It is understood that
visceral fat, specifically pre-peritoneal fat thickness, has
been identified in the production of excess adipokines
which play a role in increased insulin resistance by dis-
rupting post-insulin signalling mechanisms, thus con-
tributing to the pathogensis of gestational diabetes
mellitus [20, 21]. It has also been associated with an in-
crease in other cardio-metabolic risk factors within vari-
ous studies [12, 22–24]. The role of subcutaneous fat in
the development of obesity related disorders remains
controversial according to a recent review by Bazzocchi,
et al. [3]. The review attributes contradictory findings
from investigations of subcutaneous fat [25, 26], to the
variation in location of the measurement and lack of
consistency in the methods used to capture this specific
depot of adipose [27].
To be clinically useful within a pregnant population,
reliability and reproducibility of abdominal fat quantifi-
cation needed to be assessed within this specific popula-
tion. Therefore, this study sought to standardise and
outline a technically rigorous methodology used to
quantify abdominal adipose tissue in pregnant women,
and to segment this into its constituents, visceral (VAT)
measured as the pre-peritoneal fat thickness, and sub-
cutaneous adipose tissue (SAT) as the minimum abdom-
inal subcutaneous fat thickness. Subsequently, both
inter- and intra-observer variability were assessed in




Thirty subjects were recruited prospectively. These sub-
jects were attending the University Maternity Hospital
Limerick (Ireland) for their first routine antenatal visit at
12-weeks gestation, at which an ultrasound scan is rou-
tinely performed. Informed consent was sought and
granted (REC 082/17) in accordance with the ethical rec-
ommendations of Health Service Executive (HSE) Mid
Western Hospital Research Ethics Committee.
Ultrasonography
Measurements of adipose tissue were taken via abdom-
inal ultrasonography (US) using a GE Voluson E8
employing a 1–5MHz curvilinear array transducer. This
transducer was a practical choice as it required no
changeover from the preceding obstetric scan, and the
frequency was sufficiently high to provide adequate reso-
lution at the shallow depth of measurement.
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With the patient in a supine position and the trans-
ducer perpendicular to the skin, the required image was
obtained in sagittal plane at the xiphisternum, producing
a longitudinal view of the left lobe of liver and the aorta
(see Fig. 1). Minimal pressure was exerted on the skin,
in order to avoid compression of the adipose tissue. The
transducer was rocked left to right, in order to identify
the narrowest projection of the linea alba. The scan
depth was reduced; excluding the aorta from the image.
The sector width was reduced to 40 degrees; increasing
line density. Thus, an image of both layers of adipose tis-
sue was obtained with the inferior part of the left lobe of
liver seen posteriorly (see Fig. 2a and b). At this point,
the time gain compensation (TGC) and overall gain were
adjusted carefully to allow clear visualisation of subcuta-
neous adipose tissue and homogenous echogenicity
within the left lobe of liver. The image was then frozen.
Calipers were placed to measure in millimetres. Sub-
cutaneous fatty tissue was measured from the lower
border of the cutaneous layer to the upper border of the
linea alba and visceral fatty tissue was measured from
the lower border of linea alba to the upper border of
the liver capsule.
The US measurements were performed at the time of
routine first trimester ultrasound examination. Both ob-
servers took 3 measurements each of both VAT and
SAT on 30 subjects. A new image was acquired between
each set of measurements. The second observer entered
the examination room once the first observer’s measure-
ments were completed and removed from the screen.
All six images were saved using ViewPoint™, GE’s ultra-
sound image management and reporting solution soft-
ware and were identified with each observers’ initials
prior to transfer. Measurements recorded by observer 1
where undertaken by an obstetrician, and measurements
by observer 2 where undertaken by a trained radiog-
rapher. Both observers were regularly involved in ante-
natal scanning at this clinical site.
Statistical methods
SAT and VAT on 30 subjects were obtained by two ob-
servers, (coded here as K and C). Each measurement was
replicated 3 times, (with the exception of one occasion
where observer K made just two replicate measurements
of subcutaneous fat on a particular subject).
Intra-observer precision was assessed using Coefficient-
of-Variation (Table 1). Inter-observer reliability was assessed
using Coefficient-of-variation, and precision expressed as
repeatability standard deviations (SD) and their respective
coefficients, as well as Limits-of-Agreement. Graphical com-
parisons of the measurements obtained by the two ob-
servers were made using Bland-Altman plots showing
unlinked replicates [28]. These were generated using the
method comparison studies R package MethComp [29]
which determines the LoA by fitting a variance component
model that assumes unlinked replicates [30]. Comparison
plots were constructed (see Figs. 3a, b and 4a, b). Estimates
of the LoA were obtained from the corresponding variance
component model.
Results
Intra-observer precision was assessed by co-efficient of
variation. The data are presented in Table 1. Intra-
observer precision was to an acceptable degree accord-
ing to anthropometric criterion. Measurements of SAT
Fig. 1 Example ultrasound screenshot image at correct position for measurement of SAT (1) and VAT (2)
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and total adipose for both observers was < 5% CV and
level for VAT < 10% CV for both observers.
Inter-observer precision and repeatability was also
assessed by co-efficient of variation, with %CV of 3.05, 7.15
and 2.95% for SAT, VAT and total adipose respectively.
Inter-observer repeatability standard deviations and coeffi-
cients are presented in Table 2.
Inter-observer reliability was also assessed by LoA. De-
terminations by each of the two observers was made in
triplicate. LoA were determined to be − 0.45 to 0.46 cm
for SAT and − 0.34 to 0.53 cm for VAT values. System-
atic bias of SAT measurement was 0.01 cm and VAT,
0.10 cm (p > 0.05).
Discussion
The results of this reliability study show that intra-
abdominal ultrasound, using a strict protocol, is a reli-
able method to assess the amount of subcutaneous and
visceral adipose tissue. Within the same operator, intra-
observer precision is acceptable for measures of SAT,
VAT and total adipose, with higher precision in SAT
values than VAT. Between different operators, inter-
observer reliability assessed by LoA confirm anthropo-
metrically reliable to 0.5 cm. Systematic bias was
Fig. 2 a Anatomical schematic representation of xiphisternum in relation to positioning of ultrasound probe. b Anatomical schematic of
ultrasound image to illustrate anatomical landmarks and positioning. SAT Subcutaneous Adipose Tissue; VAT Visceral Adipose Tissue
(pre-peritoneal fat)
Table 1 Coefficient of variation (CV) for observer 1 and observer
2 based on triplicate measures of SAT, VAT and total adipose
(SAT + VAT) on replicates (n = 30)
Observer 1 Observer 2
Thickness (cm) Mean (±SD) %CV Mean (±SD) %CV
SAT 1.5 ± 0.1 2.6 1.5 ± 0.1 3.5
VAT 1.0 ± 0.1 5.8 0.9 ± 0.1 8.5
Total adipose 2.5 ± 0.1 2.6 2.4 ± 0.1 3.3
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minimal for both measures falling within 95% confidence
intervals.
Adipose tissue has been previously measured via vari-
ous specific methodologies, to produce different indices
including intra-abdominal fat, abdominal wall fat index,
pre-peritoneal fat, mesenteric fat and several others.
These have been defined and characterised based on the
specific anatomical sites utilized to measure them, as
well as specific conditions such as fasting and breathe
exhalation. As well as characterizing these methodolo-
gies, Bazzocchi et al., [3] compiles the work around the
validation of these measures via ultrasound technique
Fig. 3 a & b Graphical comparisons of the measurements obtained for SAT by the two observers were made using Bland-Altman plots showing
unlinked replicates (a). On the right; Plot of difference between measures of observer 1 and observer 2 against the mean of the two
measurements of SAT (b). Solid line represents the mean; upper line shows the mean + 1.96 SD and lower line the mean − 1.96 SD
Fig. 4 a & b Graphical comparisons of the measurements obtained for VAT by the two observers were made using Bland-Altman plots showing
unlinked replicates (a). On the right; Plot of difference between measures of observer 1 and observer 2 against the mean of the two
measurements of VAT (b). Solid line represents the mean; upper line shows the mean + 1.96 SD and lower line the mean − 1.96 SD
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against the gold standard CT scanning and their repro-
ducibility (intra -observer and inter- observer reliability).
Pre-peritoneal fat thickness, (defined as the measure-
ment taken on xiphoumbilical line just below the xiph-
oid process, as the major distance between the anterior
surface of the peritoneum covering the liver lobe, to the
posterior surface of the linea alba) is the specific ab-
dominal adipose index measured in this study, and has
been validated with success against CT imaging in recent
times [8], demonstrated strong correlation between the
CT imaging and US techniques (Lin’s correlation
coefficient of 0.85–0.87). Minimum Subcutaneous fat
thickness (determined as the distance between the
anterior surface of the linea alba and the peritoneum
covering the liver lobe, in the same anatomical place of
maximum preperitoneal fat thickness) also had excel-
lent correlation with CT imaging (Lin’s correlation
coefficient of 0.94–0.96). Inter and intra-observer
reliability has also been found to be very acceptable in
obese and non-obese patients, with coefficients of vari-
ation reported between 4.3 and 6.4% [8, 12]. Reliability
of these measures has never been tested in a pregnant
population, and this is important as hydration of tissue
changes during pregnancy, affects compressibility of
tissues and therefore potentially introducing a source
of error whilst undertaking measurements [31, 32].
Thus, this study contributes to this area of research in
a population where the obesity epidemic is pertinent
and timely.
The link between metabolic health and adiposity in
pregnancy is currently a fertile ground of research
[33–36]. Excessive accumulation of adipose tissue into
the viscera, has been implicated in increased risk of
cardio-metabolic risk [13, 37, 38] and diabetes melli-
tus [13, 38–40]. Further to this, some studies have in-
vestigated measures of abdominal adipose tissue in
early pregnancy, and established its ability to predict
glucose intolerance and gestational diabetes in later
pregnancy [41–46]. These research investigations give
insight into how measures in early pregnancy can play
an important role in earlier diagnosis and/or interven-
tion, at a time when there is established contact with
healthcare professionals [47]. Further to this, early de-
tection of risk or diagnosis of gestational diabetes in
pregnancy has been found to be critical in improving
outcomes of various types of interventions, with diet-
ary [48]; exercise [49]; pharmacological [50] interven-
tion, as well a combination of these [51], showing
improved outcomes when applied for a longer time-
span.
The end of the first trimester (12 weeks gestation) is a
clinically significant clinical time-point, at which women
attend routine antenatal appointments to the maternity
hospital to undertake an ultrasound scan to determine
gestation, foetal number and to out-rule major foetal ab-
normalities. Following the scan the patient is booked in
the Antenatal Clinic; medical and pregnancy history and
any comorbidities are recorded and antenatal bloods are
drawn. This ‘booking visit’ therefore presents a special
opportunity of contact with healthcare staff which
should be utilized effectively and efficiently to identify
women at higher risk in order to improve management
of disease.
However, this specific population is difficult to re-
search with respect to obtaining ethical approval and
consent due to concerns of invasive procedures during
such a vulnerable period. The proposed US method to
measure abdominal adipose is safe, non-invasive, eco-
nomical, and does not involve any extra intervention
for the patient- such as, specific procedural preparation.
In addition, it is time-efficient, as it took the re-
searchers less than 3 minutes to record three repeated
measures on one person. We would recommend that
future studies incorporate recording time taken to take
the measurements. In practice, routine scans at ante-
natal visit are allocated 15 min each, despite variations
according to clinical requirement. Future studies exam-
ining relationships between abdominal adiposity and
pregnancy outcomes may prove to be clinically useful
in terms of risk- stratification, therefore using US as a
research tool will translate easily to an applicable tool
in practice. Currently, body mass index is used as a
risk-stratification tool during pregnancy; however, this
does not capture body composition parameters such as
abdominal adiposity, which are specifically implicated
in metabolic health [11, 12, 20, 21].
Conclusions
Ultrasound is a non-invasive, safe, quick and available
tool for quantifying adiposity in both clinical practice as
a research tool. Standardized techniques for abdominal
adiposity, specifically visceral fat thickness at the xiphoid
region (pre-peritoneal fat) has not been previously inves-
tigated in a pregnant population, thus addressing a gap
within the literature previously identified [2, 3]. There-
fore, this study offers a technique which when replicated,
Table 2 Inter-observer repeatability SDs and repeatability
coefficients (CV). SD: standard deviation of the difference
between two measurements by the same method on the item
under identical circumstances; the repeatability coefficient the
numerical extent of the prediction interval for this difference, i.e.
2*sqrt (2) *SD
SAT VAT Total adipose
SD CV SD CV SD CV
Observer 1 0.079 0.157 0.087 0.174 0.122 0.245
Observer 2 0.107 0.215 0.128 0.256 0.155 0.310
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is a highly reliable and practical tool, which does not re-
quire demanding operator training and can therefore be
implemented by researchers and clinicians during rou-
tine antenatal ultrasonography. Measurement of intra-
abdominal adipose by ultrasound is suitable for use in
prospective observational or interventional studies in
pregnant women.
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